We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+15.63%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$925M
AUM Growth
+$121M
Cap. Flow
-$1.06M
Cap. Flow %
-0.11%
Top 10 Hldgs %
22.31%
Holding
255
New
7
Increased
77
Reduced
98
Closed
5

Top Buys

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$6.4M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.73M
3
CVS icon
CVS Health
CVS
+$2.43M
4
MSFT icon
Microsoft
MSFT
+$2.14M
5
V icon
Visa
V
+$1.6M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.75M
2
CELG
Celgene Corp
CELG
+$5.4M
3
AL
Air Lease Corp
AL
+$2.84M
4
AMT icon
American Tower
AMT
+$1.93M
5
KMI icon
Kinder Morgan
KMI
+$1.36M

Sector Composition

Rank Sector Weight
1 Healthcare 16.89%
2 Technology 16.36%
3 Industrials 11.15%
4 Consumer Staples 8.91%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VGT icon
226
Vanguard Information Technology ETF
VGT
$149B
$284K 0.03%
11,328
-40
-0.4% -$929
BA icon
227
Boeing
BA
$185B
$282K 0.03%
740
-324
-30% -$125K
ENTA icon
228
Enanta Pharmaceuticals
ENTA
$400M
$263K 0.03%
+2,750
New +$247K
GWRE icon
229
Guidewire Software
GWRE
$14.2B
$263K 0.03%
2,705
– –
EFA icon
230
iShares MSCI EAFE ETF
EFA
$80.2B
$255K 0.03%
3,938
– –
CTSH icon
231
Cognizant
CTSH
$26B
$253K 0.03%
3,498
– –
BWA icon
232
BorgWarner
BWA
$13.9B
$227K 0.02%
6,702
– –
FAST icon
233
Fastenal
FAST
$59.5B
$226K 0.02%
+14,040
New +$211K
BXP icon
234
Boston Properties
BXP
$11.1B
$224K 0.02%
+1,672
New +$215K
VDC icon
235
Vanguard Consumer Staples ETF
VDC
$7.99B
$224K 0.02%
1,541
– –
XLI icon
236
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
$216K 0.02%
+2,885
New +$209K
HRB icon
237
H&R Block
HRB
$5.86B
$215K 0.02%
9,000
– –
CHTR icon
238
Charter Communications
CHTR
$18.2B
$214K 0.02%
+618
New +$204K
SAIC icon
239
Saic
SAIC
$5.35B
$210K 0.02%
+2,735
New +$193K
STT icon
240
State Street
STT
$50.7B
$210K 0.02%
3,195
-100
-3% -$6.93K
IEMG icon
241
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$206K 0.02%
+3,990
New +$202K
XXII
242
22nd Century Group
XXII
$1.48M
– –
0
– –
NMM icon
243
Navios Maritime Partners
NMM
$2.26B
$21K ﹤0.01%
1,570
– –
RAD
244
DELISTED
Rite Aid Corporation
RAD
$10K ﹤0.01%
750
– –
GSAT icon
245
Globalstar
GSAT
$10.8B
$4K ﹤0.01%
667
– –
CPB icon
246
Campbell Soup
CPB
$6.87B
– –
-6,950
Closed -$229K
IBB icon
247
iShares Biotechnology ETF
IBB
$9.77B
– –
-2,389
Closed -$230K
LIN icon
248
Linde
LIN
$226B
– –
-49,673
Closed -$7.75M
NEM icon
249
Newmont
NEM
$119B
– –
-5,800
Closed -$201K
DNB
250
DELISTED
Dun & Bradstreet
DNB
– –
-8,891
Closed -$1.27M
6 7 8 9
10

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return

Boston Family Office's Q1 2019 Portfolio in Review

As of Q1 2019, Boston Family Office held 255 positions worth $925M, up 15% from $804M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4.7%. Boston Family Office opened 7 new positions and exited 5, leaving the 255-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

  • Boston Family Office's largest Q1 2019 buy was Enanta Pharmaceuticals: 2,750 shares worth $263K.
  • Boston Family Office added most to Air Products & Chemicals in Q1 2019, an estimated $6.4M increase.
  • Boston Family Office's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $5.4M.
  • Boston Family Office fully exited Linde in Q1 2019, selling an estimated $7.75M.
  • Boston Family Office's ten largest holdings make up 22% of its $925M portfolio in Q1 2019.
  • Boston Family Office opened 7 new positions and closed 5 in Q1 2019.
  • Boston Family Office's portfolio value rose 15% quarter-over-quarter to $925M.

Based on Boston Family Office's 13F filing for Q1 2019, filed 9 May 2019.